Tesofensine
A medical-grade willpower boost, used wisely and short-term.
Oral — 0.25 mg daily starting dose for women; 0.5 mg for men; titrated per response; typically short-term (3-month course maximum in Emer's practice)
What It Is
Tesofensine is a novel triple monoamine reuptake inhibitor (SNDRI) originally researched for neurodegenerative diseases. It inhibits the reuptake of dopamine, serotonin, and noradrenaline, profoundly suppressing appetite and slightly increasing resting energy expenditure.
Mechanism
Tesofensine silences hunger pathways in the hypothalamus by silencing GABAergic appetite neurons and boosting pro-satiety signaling. In Phase II trials for obesity, tesofensine showed remarkable efficacy — patients lost about 10% of body weight in 6 months, roughly double the weight loss of orlistat or placebo at the time. Its triple mechanism often yields superior appetite control with less jitteriness since it boosts serotonin too, improving mood.
How Dr. Emer Uses It
Dr. Emer might consider tesofensine for an individual who needs appetite suppression but refuses needles, or as an adjunct in a "stacked attack" on obesity where multiple pathways are hit (GLP-1 + tesofensine can be very potent but must be monitored closely for synergistic effects on heart rate). EmerGPT might highlight to patients that "this is like a medical-grade willpower boost, but we'll use it wisely and short-term." A low dose trial for 1–2 weeks to see how the patient responds, before committing to a 3-month course. Women starting at 0.25 mg vs men at 0.5 mg.
Key Benefits
- ✓Silences GABAergic appetite neurons for profound appetite suppression
- ✓Slightly increases resting energy expenditure
- ✓Produces ~10% body weight loss in 6 months (double orlistat in Phase II trials)
- ✓Improves mood via serotonin reuptake inhibition alongside weight loss
- ✓Oral administration — useful for needle-averse patients needing metabolic support
- ✓Complements GLP-1 agonists in "stacked attack" metabolic protocols
Pairs Well With
Used In Programs
Safety & Considerations
Because it raises catecholamines, side effects include increased heart rate and blood pressure in some patients. Patients on tesofensine require baseline and periodic blood pressure and heart rate checks. They are counseled on healthy sleep and hydration (to mitigate stimulant effects), and possibly put on a low-dose beta blocker or ACE inhibitor if blood pressure creeps up. Risks (R/B/A) include mood changes (too much dopamine can cause euphoria or conversely serotonin can cause mild nausea initially) and cardiovascular strain. Currently in Phase III trials for obesity (as of 2025).
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
